Home›Stock Screener›Rossari Biotech›Quarterly Results

Rossari Biotech Quarterly Results

Latest Quarter Net Profit
₹39 Cr
QSept 2026
Quarterly Results

Rossari Biotech quarterly results. In Sept 2026, Rossari Biotech (ROSSARI) reported revenue ₹699 Cr and net profit ₹39 Cr — revenue +18.9% YoY. Also explore ROSSARI share price charts to track price trends across different timeframes.

ROSSARI Quarterly Results — Revenue, Profit & EPS Highlights

Rossari Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View ROSSARI yearly price range for the annual high/low range and current price position.

  • Revenue of ₹699 Cr in Sept 2026 (-0.7% vs Mar 2026, +18.9% vs Sept 2025)
  • Net Profit of ₹39 Cr in Sept 2026 (-15.2% vs Mar 2026, +5.4% vs Sept 2025)
  • EBITDA of ₹88 Cr in Sept 2026 (-9.3% vs Mar 2026)
  • Operating Margin of 12.0% in Sept 2026 (+1.0pp vs Mar 2026)
  • Earnings Per Share of ₹7.02 in Sept 2026 (-15.4% vs Mar 2026)

Rossari Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ROSSARI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 699 704 701 588 582 -0.7% 18.9%
Net Profit (₹ Cr) 39 46 35 37 34 - -
EBITDA (₹ Cr) 88 97 84 74 71 - -
EPS (₹) 7.02 8.30 6.34 6.66 6.22 - -
Operating Margin (%) 12.0% 11.0% 12.0% 12.0% 12.0% - -

ROSSARI Share Price Trend — 1-Year Movement Across Quarterly Results

Rossari Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Rossari Biotech share price today.

Profitability Ratios

Profit Margin 5.6%
EBITDA Margin 12.6%
Operating Margin 12.0%
ROE (Annual) 11.7%

Balance Sheet Highlights

Total Assets ₹2,289 Cr
Total Equity ₹1,333 Cr
Current Assets ₹ Cr
Current Liabilities ₹166 Cr

Cash Flow Analysis

Operating Cash Flow ₹65 Cr
Investing Cash Flow ₹-220 Cr
Financing Cash Flow ₹186 Cr
Net Cash Flow ₹31 Cr

Current Market Data

Current Price ₹428.00
Exchange NSE
Last Updated Nov 19, 2026

ROSSARI vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Rossari Biotech latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Solar Industries
Sept 2026
₹170,302.28 Cr 18850.0 3,534 650 +14.0% - 18.4% 276.4
Pidilite Industries
Sept 2026
₹155,755.95 Cr 1580.5 4,367 627 +19.7% - 14.4% 261.7
SRF
Sept 2026
₹72,475.87 Cr 2513.9 4,828 509 +5.9% - 10.5% 146.3
Linde
Sept 2026
₹58,423.96 Cr 6742.0 734 119 +18.2% - 16.2% 484.0
Coromandel Internat…
Sept 2026
₹57,802.43 Cr 1972.0 10,348 523 +70.5% - 5.1% 108.7
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores